Literature DB >> 31055973

The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease.

Ju-Yang Jung1, Chang-Hee Suh1, Hyoun-Ah Kim1.   

Abstract

Introduction: Adult-onset Still's disease (AOSD) is a systemic inflammatory disease, which presents itself as an adult form of systemic juvenile idiopathic arthritis. Innate immune activation driven by a combination of genetic and environmental factors is the primary mechanism underlying disease pathogenesis in AOSD patients. Few biomarkers have been identified for AOSD diagnosis or for the assessment of disease activity or prediction of clinical outcomes. Damage-associated molecular patterns (DAMPs) can activate innate immunity, resulting in tissue damage. Changes in several DAMPs are associated with disease pathogenesis in AOSD patients. Areas covered: This review describes the role of DAMPs in AOSD pathogenesis and discusses their potential for use as disease biomarkers. Together with overall pathogenesis of AOSD, high-mobility group box-1, advanced glycation end products, S100 proteins, and neutrophil extracellular traps are introduced and discussed in detail. Expert opinion: The activation of macrophages and neutrophils is associated with several DAMPs, causing high concentrations of proinflammatory cytokines in AOSD patients. Involvement of certain DAMPs in AOSD patients is well documented due to the presence of sterile inflammation; however, direct evidence for some DAMPs is lacking. Further research into the role of DAMP molecules in AOSD patients may reveal new biomarkers and provide targets for disease intervention.

Entities:  

Keywords:  Damage-associated molecular pattern; S100A8/A9; adult-onset Still’s disease; biomarker; pathogenesis

Mesh:

Substances:

Year:  2019        PMID: 31055973     DOI: 10.1080/14737159.2019.1615449

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  7 in total

1.  Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.

Authors:  Hideto Nagai; Yohei Kirino; Hiroto Nakano; Yosuke Kunishita; Riko Henmi; Ann Marie Szymanski; Ryusuke Yoshimi; Michael J Ombrello; Hideaki Nakajima
Journal:  Rheumatology (Oxford)       Date:  2021-08-02       Impact factor: 7.580

Review 2.  Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.

Authors:  Meng-Yan Wang; Jin-Chao Jia; Cheng-De Yang; Qiong-Yi Hu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

Review 3.  Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.

Authors:  Ju-Yang Jung; Ji-Won Kim; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Front Immunol       Date:  2020-11-05       Impact factor: 7.561

Review 4.  An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.

Authors:  Po-Ku Chen; Der-Yuan Chen
Journal:  J Immunol Res       Date:  2021-06-20       Impact factor: 4.818

5.  Case Report: Adult Still's Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient.

Authors:  Julia Krämer; Tanja Krömer-Olbrisch; Heinz-Jürgen Lakomek; Peter D Schellinger; Dirk Foell; Sven G Meuth; Vera Straeten
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

6.  Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.

Authors:  Jinchao Jia; Luyu Yang; Zhujun Cao; Mengyan Wang; Yuning Ma; Xiong Ma; Qiaoyan Liu; Jialin Teng; Hui Shi; Honglei Liu; Xiaobing Cheng; Junna Ye; Yutong Su; Yue Sun; Huihui Chi; Tingting Liu; Zhihong Wang; Liyan Wan; Chengde Yang; Qiongyi Hu
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

Review 7.  Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.

Authors:  Beatrice Maranini; Giovanni Ciancio; Marcello Govoni
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.